메뉴 건너뛰기




Volumn 7, Issue 2, 2011, Pages 203-217

Delayed and indirect effects of antiarrhythmic drugs in reducing sudden cardiac death

Author keywords

antiarrhythmic drugs; sudden cardiac death

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; AZIMILIDE; BISOPROLOL; CAPTOPRIL; CARVEDILOL; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; DRONEDARONE; ENCAINIDE; EPLERENONE; FLECAINIDE; LOSARTAN; METOPROLOL; MEXILETINE; MORACIZINE; OMEGA 3 FATTY ACID; PLACEBO; PROCAINAMIDE; PROPAFENONE; QUINIDINE; RAMIPRIL; RANOLAZINE; ROSUVASTATIN; SOTALOL; SPIRONOLACTONE; TOCAINIDE; UNINDEXED DRUG; VERAPAMIL;

EID: 79953790996     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.11.3     Document Type: Review
Times cited : (11)

References (78)
  • 1
    • 35748971738 scopus 로고    scopus 로고
    • Global public health problem of sudden cardiac death
    • Mehra R: Global public health problem of sudden cardiac death. J. Electrocardiol. 40(Suppl. 6), S118-S122 (2007).
    • (2007) J. Electrocardiol. , vol.40 , Issue.SUPPL. 6
    • Mehra, R.1
  • 3
    • 0027495655 scopus 로고
    • Sudden cardiac death: Epidemiology, transient risk, and intervention assessment
    • Myerburg RJ, Kessler KM, Castellanos A: Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann. Intern. Med. 119(12), 1187-1197 (1993).
    • (1993) Ann. Intern. Med. , vol.119 , Issue.12 , pp. 1187-1197
    • Myerburg, R.J.1    Kessler, K.M.2    Castellanos, A.3
  • 5
    • 33646394262 scopus 로고    scopus 로고
    • Epidemiology and mechanisms of sudden cardiac death
    • Zipes DP: Epidemiology and mechanisms of sudden cardiac death. Can. J. Cardiol. 21(Suppl. A), 37-40 (2005).
    • (2005) Can. J. Cardiol. , vol.21 , Issue.SUPPL. A , pp. 37-40
    • Zipes, D.P.1
  • 8
    • 1542401214 scopus 로고    scopus 로고
    • Inappropriate ICD therapy due to proarrhythmic ICD shocks and hyperpolarization
    • Healy E, Goyal S, Browning C et al.: Inappropriate ICD therapy due to proarrhythmic ICD shocks and hyperpolarization. Pacing Clin. Electrophysiol. 27(3), 415-416 (2004).
    • (2004) Pacing Clin. Electrophysiol. , vol.27 , Issue.3 , pp. 415-416
    • Healy, E.1    Goyal, S.2    Browning, C.3
  • 9
    • 0026050195 scopus 로고
    • The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms
    • Task force of the working group on arrhythmias of the European Society of Cardiology
    • The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task force of the working group on arrhythmias of the European Society of Cardiology. Circulation 84(4), 1831-1851 (1991).
    • (1991) Circulation , vol.84 , Issue.4 , pp. 1831-1851
  • 11
    • 0027396908 scopus 로고
    • Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results
    • Maggioni AP, Zuanetti G, Franzosi MG et al.: Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 87(2), 312-322 (1993).
    • (1993) Circulation , vol.87 , Issue.2 , pp. 312-322
    • Maggioni, A.P.1    Zuanetti, G.2    Franzosi, M.G.3
  • 12
    • 0021278098 scopus 로고
    • Risk factors for sudden death after acute myocardial infarction: Two-year follow-up
    • Mukharji J, Rude RE, Poole WK et al.: Risk factors for sudden death after acute myocardial infarction: two-year follow-up. Am. J. Cardiol. 54(1), 31-36 (1984).
    • (1984) Am. J. Cardiol. , vol.54 , Issue.1 , pp. 31-36
    • Mukharji, J.1    Rude, R.E.2    Poole, W.K.3
  • 13
    • 0024321898 scopus 로고
    • Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
    • The Cardiac Arrhythmia Suppression Trial (CAST) investigators Increased arrhythmic and nonarrhythmic mortality with class 1 agents among postmyocardial infarction (MI) I patients even after effective suppression of premature ventricular complexes
    • Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) investigators. N. Engl. J. Med. 321(6), 406-412 (1989). Increased arrhythmic and nonarrhythmic mortality with class 1 agents among postmyocardial infarction (MI) I patients even after effective suppression of premature ventricular complexes.
    • (1989) N. Engl. J. Med. , vol.321 , Issue.6 , pp. 406-412
  • 14
    • 0026752875 scopus 로고
    • Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
    • The Cardiac Arrhythmia Suppression Trial II investigators Demonstrates early mortality from morcizine among post-MI patients when compared with placebo
    • Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial II investigators. N. Engl. J. Med. 327(4), 227-233 (1992). Demonstrates early mortality from morcizine among post-MI patients when compared with placebo.
    • (1992) N. Engl. J. Med. , vol.327 , Issue.4 , pp. 227-233
  • 15
    • 0033840161 scopus 로고    scopus 로고
    • Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH)
    • Kuck KH, Cappato R, Siebels J, Ruppel R: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102(7), 748-754 (2000).
    • (2000) Circulation , vol.102 , Issue.7 , pp. 748-754
    • Kuck, K.H.1    Cappato, R.2    Siebels, J.3    Ruppel, R.4
  • 16
    • 0030750292 scopus 로고    scopus 로고
    • Antiarrhythmic therapies for the prevention of sudden cardiac death
    • McAlister FA, Teo KK: Antiarrhythmic therapies for the prevention of sudden cardiac death. Drugs 54(2), 235-252 (1997).
    • (1997) Drugs , vol.54 , Issue.2 , pp. 235-252
    • McAlister, F.A.1    Teo, K.K.2
  • 17
    • 33748575897 scopus 로고    scopus 로고
    • ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines
    • Zipes DP, Camm AJ, Borggrefe M et al.: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(10), e385-e484 (2006).
    • (2006) Circulation , vol.114 , Issue.10
    • Zipes, D.P.1    Camm, A.J.2    Borggrefe, M.3
  • 18
    • 0033549290 scopus 로고    scopus 로고
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353(9169), 2001-2007 (1999).
    • (1999) Lancet , vol.353 , Issue.9169 , pp. 2001-2007
  • 19
    • 0033514046 scopus 로고    scopus 로고
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353(9146), 9-13 (1999).
    • (1999) Lancet , vol.353 , Issue.9146 , pp. 9-13
  • 20
    • 0035978763 scopus 로고    scopus 로고
    • Effect of carvedilol on survival in severe chronic heart failure
    • Packer M, Coats AJ, Fowler MB et al.: Effect of carvedilol on survival in severe chronic heart failure. N. Engl. J. Med. 344(22), 1651-1658 (2001).
    • (2001) N. Engl. J. Med. , vol.344 , Issue.22 , pp. 1651-1658
    • Packer, M.1    Coats, A.J.2    Fowler, M.B.3
  • 21
    • 0035810547 scopus 로고    scopus 로고
    • Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial
    • Dargie HJ: Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357(9266), 1385-1390 (2001).
    • (2001) Lancet , vol.357 , Issue.9266 , pp. 1385-1390
    • Dargie, H.J.1
  • 22
    • 77949511960 scopus 로고    scopus 로고
    • Arrhythmias originating from the right ventricular outflow tract: How to distinguish 'malignant' from 'benign'?
    • Shimizu W: Arrhythmias originating from the right ventricular outflow tract: how to distinguish 'malignant' from 'benign'? Heart Rhythm 6(10), 1507-1511 (2009).
    • (2009) Heart Rhythm , vol.6 , Issue.10 , pp. 1507-1511
    • Shimizu, W.1
  • 23
    • 65649109353 scopus 로고    scopus 로고
    • Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery
    • Collura CA, Johnson JN, Moir C, Ackerman MJ: Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. Heart Rhythm 6(6), 752-759 (2009).
    • (2009) Heart Rhythm , vol.6 , Issue.6 , pp. 752-759
    • Collura, C.A.1    Johnson, J.N.2    Moir, C.3    Ackerman, M.J.4
  • 24
    • 0020051070 scopus 로고
    • Controlled trial of sotalol for one year after myocardial infarction
    • Julian DG, Prescott RJ, Jackson FS, Szekely P: Controlled trial of sotalol for one year after myocardial infarction. Lancet 1(8282), 1142-1147 (1982).
    • (1982) Lancet , vol.1 , Issue.8282 , pp. 1142-1147
    • Julian, D.G.1    Prescott, R.J.2    Jackson, F.S.3    Szekely, P.4
  • 25
    • 8944234858 scopus 로고    scopus 로고
    • Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD investigators. Survival with oral d-sotalol
    • Demonstrates overall and arrhythmic mortality from d-sotalol as compared with placebo among patients with recent MI or ischemic cardiomyopathy (ICM)
    • Waldo AL, Camm AJ, Deruyter H et al.: Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD investigators. Survival with oral d-sotalol. Lancet 348(9019), 7-12 (1996). Demonstrates overall and arrhythmic mortality from d-sotalol as compared with placebo among patients with recent MI or ischemic cardiomyopathy (ICM).
    • (1996) Lancet , vol.348 , Issue.9019 , pp. 7-12
    • Waldo, A.L.1    Camm, A.J.2    Deruyter, H.3
  • 26
    • 0033578076 scopus 로고    scopus 로고
    • Prevention of implantable-defibrillator shocks by treatment with sotalol
    • D, l-sotalol implantable cardioverter-defibrillator study group
    • Pacifico A, Hohnloser SH, Williams JH et al.: Prevention of implantable-defibrillator shocks by treatment with sotalol. D, l-sotalol implantable cardioverter-defibrillator study group. N. Engl. J. Med. 340(24), 1855-1862 (1999).
    • (1999) N. Engl. J. Med. , vol.340 , Issue.24 , pp. 1855-1862
    • Pacifico, A.1    Hohnloser, S.H.2    Williams, J.H.3
  • 27
    • 0031038213 scopus 로고    scopus 로고
    • Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: Emiat
    • European Myocardial Infarct Amiodarone Trial investigators Trial demonstrated a nonsignificant mortality benefit from amiodarone in post-MI patients
    • Julian DG, Camm AJ, Frangin G et al.: Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: emiat. European Myocardial Infarct Amiodarone Trial investigators. Lancet 349(9053), 667-674 (1997). Trial demonstrated a nonsignificant mortality benefit from amiodarone in post-MI patients.
    • (1997) Lancet , vol.349 , Issue.9053 , pp. 667-674
    • Julian, D.G.1    Camm, A.J.2    Frangin, G.3
  • 28
    • 0030905309 scopus 로고    scopus 로고
    • Amiodarone after myocardial infarction: EMIAT and CAMIAT trials
    • Malik M, Camm AJ: Amiodarone after myocardial infarction: EMIAT and CAMIAT trials. Lancet 349(9067), 1767-1768 (1997).
    • (1997) Lancet , vol.349 , Issue.9067 , pp. 1767-1768
    • Malik, M.1    Camm, A.J.2
  • 29
    • 0025809809 scopus 로고
    • Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian amiodarone myocardial infarction arrhythmia trial pilot study
    • Nonsignificant mortality benefit from amiodarone, but a significant decrease in arrhythmic deaths among post-MI patients
    • Cairns JA, Connolly SJ, Gent M, Roberts R: Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian amiodarone myocardial infarction arrhythmia trial pilot study. Circulation 84(2), 550-557 (1991). Nonsignificant mortality benefit from amiodarone, but a significant decrease in arrhythmic deaths among post-MI patients.
    • (1991) Circulation , vol.84 , Issue.2 , pp. 550-557
    • Cairns, J.A.1    Connolly, S.J.2    Gent, M.3    Roberts, R.4
  • 30
    • 0027998462 scopus 로고
    • Randomized trial of low-dose amiodarone in severe congestive heart failure
    • Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)
    • Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R: Randomized trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 344(8921), 493-498 (1994).
    • (1994) Lancet , vol.344 , Issue.8921 , pp. 493-498
    • Doval, H.C.1    Nul, D.R.2    Grancelli, H.O.3    Perrone, S.V.4    Bortman, G.R.5    Curiel, R.6
  • 31
    • 66249127922 scopus 로고    scopus 로고
    • Amiodarone for the prevention of sudden cardiac death: A meta-ana lysis of randomized controlled trials
    • A meta-ana lysis of 13 trials demonstrating significant reduction in sudden cardiac death (SCD) and cardiovascular mortality with amiodarone as compared with placebo. No significant reduction in all-cause mortality
    • Piccini JP, Berger JS, O'Connor CM: Amiodarone for the prevention of sudden cardiac death: a meta-ana lysis of randomized controlled trials. Eur. Heart J. 30(10), 1245-1253 (2009). A meta-ana lysis of 13 trials demonstrating significant reduction in sudden cardiac death (SCD) and cardiovascular mortality with amiodarone as compared with placebo. No significant reduction in all-cause mortality.
    • (2009) Eur. Heart J. , vol.30 , Issue.10 , pp. 1245-1253
    • Piccini, J.P.1    Berger, J.S.2    O'Connor, C.M.3
  • 32
    • 19944429413 scopus 로고    scopus 로고
    • Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
    • Sudden Cardiac Death in Heart Failure trial: reduction in mortality in patients with ICM and nonischemic cardiomyopathy with the use of implantable cardioverter defibrillator when compared with placebo. No mortality benefit from amiodarone use
    • Bardy GH, Lee KL, Mark DB et al.: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352(3), 225-237 (2005). Sudden Cardiac Death in Heart Failure trial: reduction in mortality in patients with ICM and nonischemic cardiomyopathy with the use of implantable cardioverter defibrillator when compared with placebo. No mortality benefit from amiodarone use.
    • (2005) N. Engl. J. Med. , vol.352 , Issue.3 , pp. 225-237
    • Bardy, G.H.1    Lee, K.L.2    Mark, D.B.3
  • 33
    • 0034676762 scopus 로고    scopus 로고
    • Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: A randomised trial
    • Kober L, Bloch-Thomsen PE, Moller M et al.: Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. Lancet 356(9247), 2052-2058 (2000).
    • (2000) Lancet , vol.356 , Issue.9247 , pp. 2052-2058
    • Kober, L.1    Bloch-Thomsen, P.E.2    Moller, M.3
  • 34
    • 0033575989 scopus 로고    scopus 로고
    • Dofetilide in patients with congestive heart failure and left ventricular dysfunction
    • Danish Investigations of Arrhythmia and Mortality on Dofetilide study group
    • Torp-Pedersen C, Moller M, Bloch-Thomsen PE et al.: Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide study group. N. Engl. J. Med. 341(12), 857-865 (1999).
    • (1999) N. Engl. J. Med. , vol.341 , Issue.12 , pp. 857-865
    • Torp-Pedersen, C.1    Moller, M.2    Bloch-Thomsen, P.E.3
  • 35
    • 0035853102 scopus 로고    scopus 로고
    • QTc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide
    • A substudy of Danish Investigations of Arrhythmia and Mortality on Dofetilide-Congestive Heart Failure (CHF) demonstrated a significant survival benefit in patients with CHF and a QTc less than 429 ms
    • Brendorp B, Elming H, Jun L et al.: QTc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide. Circulation 103(10), 1422-1427 (2001). A substudy of Danish Investigations of Arrhythmia and Mortality on Dofetilide-Congestive Heart Failure (CHF) demonstrated a significant survival benefit in patients with CHF and a QTc less than 429 ms.
    • (2001) Circulation , vol.103 , Issue.10 , pp. 1422-1427
    • Brendorp, B.1    Elming, H.2    Jun, L.3
  • 36
    • 60549097431 scopus 로고    scopus 로고
    • Effect of dronedarone on cardiovascular events in atrial fibrillation
    • Hohnloser SH, Crijns HJ, Van Eickels M et al.: Effect of dronedarone on cardiovascular events in atrial fibrillation. N. Engl. J. Med. 360(7), 668-678 (2009).
    • (2009) N. Engl. J. Med. , vol.360 , Issue.7 , pp. 668-678
    • Hohnloser, S.H.1    Crijns, H.J.2    Van Eickels, M.3
  • 37
    • 45549094153 scopus 로고    scopus 로고
    • Increased mortality after dronedarone therapy for severe heart failure
    • Increased mortality from CHF among those treated with dronedarone
    • Kober L, Torp-Pedersen C, Mcmurray JJ et al.: Increased mortality after dronedarone therapy for severe heart failure. N. Engl. J. Med. 358(25), 2678-2687 (2008). Increased mortality from CHF among those treated with dronedarone.
    • (2008) N. Engl. J. Med. , vol.358 , Issue.25 , pp. 2678-2687
    • Kober, L.1    Torp-Pedersen, C.2    Mcmurray, J.J.3
  • 38
    • 1442335812 scopus 로고    scopus 로고
    • Mortality in patients after a recent myocardial infarction: A randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification
    • Camm AJ, Pratt CM, Schwartz PJ et al.: Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation 109(8), 990-996 (2004).
    • (2004) Circulation , vol.109 , Issue.8 , pp. 990-996
    • Camm, A.J.1    Pratt, C.M.2    Schwartz, P.J.3
  • 39
    • 44449103129 scopus 로고    scopus 로고
    • Role of drug therapy for sustained ventricular tachyarrhythmias
    • Mitchell LB: Role of drug therapy for sustained ventricular tachyarrhythmias. Cardiol. Clin. 26(3), 405-418, vi (2008).
    • (2008) Cardiol. Clin. , vol.26 , Issue.3
    • Mitchell, L.B.1
  • 40
    • 0034126206 scopus 로고    scopus 로고
    • The antiarrhythmic potential of angiotensin II antagonism: Experience with losartan
    • Gavras I, Gavras H: The antiarrhythmic potential of angiotensin II antagonism: experience with losartan. Am. J. Hypertens. 13, 512-517 (2000).
    • (2000) Am. J. Hypertens. , vol.13 , pp. 512-517
    • Gavras, I.1    Gavras, H.2
  • 41
    • 0027398331 scopus 로고
    • Distribution of left ventricular sympathetic afferents demonstrated by reflex responses to transmural myocardial ischemia and to intracoronary and epicardial bradykinin
    • Minisi A, Thames M: Distribution of left ventricular sympathetic afferents demonstrated by reflex responses to transmural myocardial ischemia and to intracoronary and epicardial bradykinin. Circulation 87(1), 240-246 (1993).
    • (1993) Circulation , vol.87 , Issue.1 , pp. 240-246
    • Minisi, A.1    Thames, M.2
  • 42
    • 0141724739 scopus 로고    scopus 로고
    • Use of nonantiarrhythmic drugs for prevention of sudden cardiac death
    • Alberte C, Zipes DP: Use of nonantiarrhythmic drugs for prevention of sudden cardiac death. J. Cardiovasc. Electrophysiol. 14(Suppl. 9), S87-S95 (2003).
    • (2003) J. Cardiovasc. Electrophysiol. , vol.14 , Issue.SUPPL. 9
    • Alberte, C.1    Zipes, D.P.2
  • 43
    • 0027980446 scopus 로고
    • Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy
    • Pogwizd S: Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy. Circulation 90(3), 1441-1458 (1994).
    • (1994) Circulation , vol.90 , Issue.3 , pp. 1441-1458
    • Pogwizd, S.1
  • 44
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensinconverting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
    • The Heart Outcomes Prevention Evaluation study investigators Heart Outcomes Prevention Evaluation study: ramipril significantly reduces cardiovascular mortality and cardiac arrest among those with vascular disease or diabetes and cardiovascular risk factors
    • Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensinconverting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation study investigators. N. Engl. J. Med. 342(3), 145-153 (2000). Heart Outcomes Prevention Evaluation study: ramipril significantly reduces cardiovascular mortality and cardiac arrest among those with vascular disease or diabetes and cardiovascular risk factors.
    • (2000) N. Engl. J. Med. , vol.342 , Issue.3 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3    Bosch, J.4    Davies, R.5    Dagenais, G.6
  • 45
    • 0033101663 scopus 로고    scopus 로고
    • Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-ana lysis of randomized clinical trials
    • Domanski MJ, Exner DV, Borkowf CB, Geller NL, Rosenberg Y, Pfeffer MA: Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-ana lysis of randomized clinical trials. J. Am. Coll. Cardiol. 33(3), 598-604 (1999).
    • (1999) J. Am. Coll. Cardiol. , vol.33 , Issue.3 , pp. 598-604
    • Domanski, M.J.1    Exner, D.V.2    Borkowf, C.B.3    Geller, N.L.4    Rosenberg, Y.5    Pfeffer, M.A.6
  • 46
    • 0028955321 scopus 로고
    • Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
    • Collaborative group on ACE inhibitor trials A meta-ana lysis of randomized controlled trials demonstrated significant reduction in all-cause mortality from ACE inhibitor use, but no reduction in the incidence of SCD
    • Garg R, Yusuf S: Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative group on ACE inhibitor trials. JAMA 273(18), 1450-1456 (1995). A meta-ana lysis of randomized controlled trials demonstrated significant reduction in all-cause mortality from ACE inhibitor use, but no reduction in the incidence of SCD.
    • (1995) JAMA , vol.273 , Issue.18 , pp. 1450-1456
    • Garg, R.1    Yusuf, S.2
  • 47
    • 0037036971 scopus 로고    scopus 로고
    • Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: The OPTIMAL randomized trial. Optimal trial in myocardial infarction with angiotensin II antagonist losartan
    • Similar incidence of all death, SCD and cardiac arrest among those treated with losartan as compared with captopril
    • Dickstein K, Kjekshus J: Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomized trial. Optimal trial in myocardial infarction with angiotensin II antagonist losartan. Lancet 360(9335), 752-760 (2002). Similar incidence of all death, SCD and cardiac arrest among those treated with losartan as compared with captopril.
    • (2002) Lancet , vol.360 , Issue.9335 , pp. 752-760
    • Dickstein, K.1    Kjekshus, J.2
  • 48
    • 0037028607 scopus 로고    scopus 로고
    • Angiotensin receptor blockers in heart failure: Meta-ana lysis of randomized controlled trials
    • Jong P, Demers C, Mckelvie RS, Liu PP: Angiotensin receptor blockers in heart failure: meta-ana lysis of randomized controlled trials. J. Am. Coll. Cardiol. 39(3), 463-470 (2002).
    • (2002) J. Am. Coll. Cardiol. , vol.39 , Issue.3 , pp. 463-470
    • Jong, P.1    Demers, C.2    Mckelvie, R.S.3    Liu, P.P.4
  • 49
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure
    • Randomized aldactone evaluation study investigators Randomized Aldactone Evaluation Study: significant reduction in cardiac death (mainly from progression of CHF) with the use of spironolactone among those with advanced CHF
    • Pitt B, Zannad F, Remme WJ et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N. Engl. J. Med. 341(10), 709-717 (1999). Randomized Aldactone Evaluation Study: significant reduction in cardiac death (mainly from progression of CHF) with the use of spironolactone among those with advanced CHF.
    • (1999) N. Engl. J. Med. , vol.341 , Issue.10 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3
  • 50
    • 0037417252 scopus 로고    scopus 로고
    • Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
    • Pitt B, Remme W, Zannad F et al.: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348(14), 1309-1321 (2003).
    • (2003) N. Engl. J. Med. , vol.348 , Issue.14 , pp. 1309-1321
    • Pitt, B.1    Remme, W.2    Zannad, F.3
  • 51
    • 34548786696 scopus 로고    scopus 로고
    • Statin therapy in heart failure: Prognostic effects and potential mechanisms
    • Shanes JG, Minadeo KN, Moret A, Groner M, Tabaie SA: Statin therapy in heart failure: prognostic effects and potential mechanisms. Am. Heart J. 154(4), 617-623 (2007).
    • (2007) Am. Heart J. , vol.154 , Issue.4 , pp. 617-623
    • Shanes, J.G.1    Minadeo, K.N.2    Moret, A.3    Groner, M.4    Tabaie, S.A.5
  • 52
    • 32644453882 scopus 로고    scopus 로고
    • Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
    • Vyas A, Guo H, Moss A et al.: Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J. Am. Coll. Cardiol. 47(4), 769-773 (2006).
    • (2006) J. Am. Coll. Cardiol. , vol.47 , Issue.4 , pp. 769-773
    • Vyas, A.1    Guo, H.2    Moss, A.3
  • 53
    • 33748572257 scopus 로고    scopus 로고
    • Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy
    • Goldberger JJ, Subacius H, Schaechter A et al.: Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. J. Am. Coll. Cardiol. 48(6), 1228-1233 (2006).
    • (2006) J. Am. Coll. Cardiol. , vol.48 , Issue.6 , pp. 1228-1233
    • Goldberger, J.J.1    Subacius, H.2    Schaechter, A.3
  • 54
    • 36549030340 scopus 로고    scopus 로고
    • Rosuvastatin in older patients with systolic heart failure
    • No mortality benefit was seen with the use of rosuvastatin among patients with ICM. But there were fewer hospitalizations from cardiovascular cause among those treated with rosuvastatin
    • Kjekshus J, Apetrei E, Barrios V et al.: Rosuvastatin in older patients with systolic heart failure. N. Engl. J. Med. 357(22), 2248-2261 (2007). No mortality benefit was seen with the use of rosuvastatin among patients with ICM. But there were fewer hospitalizations from cardiovascular cause among those treated with rosuvastatin.
    • (2007) N. Engl. J. Med. , vol.357 , Issue.22 , pp. 2248-2261
    • Kjekshus, J.1    Apetrei, E.2    Barrios, V.3
  • 55
    • 53049095795 scopus 로고    scopus 로고
    • Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): A randomized, double-blind, placebo-controlled trial
    • No mortality benefit and no reduction in hospitalization with rosuvastatin use among those with ICM or nonischemic cardiomyopathy
    • Tavazzi L, Maggioni AP, Marchioli R et al.: Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet 372(9645), 1231-1239 (2008). No mortality benefit and no reduction in hospitalization with rosuvastatin use among those with ICM or nonischemic cardiomyopathy.
    • (2008) Lancet , vol.372 , Issue.9645 , pp. 1231-1239
    • Tavazzi, L.1    Maggioni, A.P.2    Marchioli, R.3
  • 56
    • 43249091138 scopus 로고    scopus 로고
    • Fish oil fatty acids as cardiovascular drugs
    • Leaf A, Kang JX, Xiao YF: Fish oil fatty acids as cardiovascular drugs. Curr. Vasc. Pharmacol. 6(1), 1-12 (2008).
    • (2008) Curr. Vasc. Pharmacol. , vol.6 , Issue.1 , pp. 1-12
    • Leaf, A.1    Kang, J.X.2    Xiao, Y.F.3
  • 57
    • 33644878048 scopus 로고    scopus 로고
    • Dietary a-linolenic acid intake and risk of sudden cardiac death and coronary heart disease
    • Albert CM, Oh K, Whang W et al.: Dietary a-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation 112(21), 3232-3238 (2005).
    • (2005) Circulation , vol.112 , Issue.21 , pp. 3232-3238
    • Albert, C.M.1    Oh, K.2    Whang, W.3
  • 58
    • 0037161373 scopus 로고    scopus 로고
    • Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course ana lysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione
    • Marchioli R, Barzi F, Bomba E et al.: Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course ana lysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105(16), 1897-1903 (2002).
    • (2002) Circulation , vol.105 , Issue.16 , pp. 1897-1903
    • Marchioli, R.1    Barzi, F.2    Bomba, E.3
  • 59
    • 23744492093 scopus 로고    scopus 로고
    • Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids
    • Macchia A, Levantesi G, Franzosi MG et al.: Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur. J. Heart Fail. 7(5), 904-909 (2005).
    • (2005) Eur. J. Heart Fail. , vol.7 , Issue.5 , pp. 904-909
    • Macchia, A.1    Levantesi, G.2    Franzosi, M.G.3
  • 60
    • 33745100018 scopus 로고    scopus 로고
    • Effect of fish oil on ventricular tachyarrhythmia and death inpatients with implantable cardioverter defibrillators
    • Brouwer I, Zock P, Camm A et al.: Effect of fish oil on ventricular tachyarrhythmia and death inpatients with implantable cardioverter defibrillators. J. Am. Coll. Cardiol. 295(22), 2613-2619 (2006).
    • (2006) J. Am. Coll. Cardiol. , vol.295 , Issue.22 , pp. 2613-2619
    • Brouwer, I.1    Zock, P.2    Camm, A.3
  • 61
    • 33745100018 scopus 로고    scopus 로고
    • Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: The Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial
    • Brouwer IA, Zock PL, Camm AJ et al.: Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 295(22), 2613-2619 (2006).
    • (2006) JAMA , vol.295 , Issue.22 , pp. 2613-2619
    • Brouwer, I.A.1    Zock, P.L.2    Camm, A.J.3
  • 62
    • 64849110630 scopus 로고    scopus 로고
    • Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators
    • Brouwer IA, Raitt MH, Dullemeijer C et al.: Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur. Heart J. 30(7), 820-826 (2009).
    • (2009) Eur. Heart J. , vol.30 , Issue.7 , pp. 820-826
    • Brouwer, I.A.1    Raitt, M.H.2    Dullemeijer, C.3
  • 63
    • 53049110571 scopus 로고    scopus 로고
    • Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial
    • Reduction in all-cause mortality, but not from SCD among patients treated with n-3 polyunsaturated fatty acids
    • Tavazzi L, Maggioni AP, Marchioli R et al.: Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372(9645), 1223-1230 (2008). Reduction in all-cause mortality, but not from SCD among patients treated with n-3 polyunsaturated fatty acids.
    • (2008) Lancet , vol.372 , Issue.9645 , pp. 1223-1230
    • Tavazzi, L.1    Maggioni, A.P.2    Marchioli, R.3
  • 64
    • 0026011647 scopus 로고
    • Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial
    • Echt DS, Liebson PR, Mitchell LB et al.: Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N. Engl. J. Med. 324(12), 781-788 (1991).
    • (1991) N. Engl. J. Med. , vol.324 , Issue.12 , pp. 781-788
    • Echt, D.S.1    Liebson, P.R.2    Mitchell, L.B.3
  • 65
    • 0006918490 scopus 로고    scopus 로고
    • Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
    • Multicenter automatic defibrillator implantation trial investigators
    • Moss AJ, Hall WJ, Cannom DS et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N. Engl. J. Med. 335(26), 1933-1940 (1996).
    • (1996) N. Engl. J. Med. , vol.335 , Issue.26 , pp. 1933-1940
    • Moss, A.J.1    Hall, W.J.2    Cannom, D.S.3
  • 66
    • 0037149716 scopus 로고    scopus 로고
    • Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
    • Moss AJ, Zareba W, Hall WJ et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346(12), 877-883 (2002).
    • (2002) N. Engl. J. Med. , vol.346 , Issue.12 , pp. 877-883
    • Moss, A.J.1    Zareba, W.2    Hall, W.J.3
  • 67
    • 0033576804 scopus 로고    scopus 로고
    • A randomized study of the prevention of sudden death in patients with coronary artery disease
    • Multicenter unsustained tachycardia trial investigators
    • Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. N. Engl. J. Med. 341(25), 1882-1890 (1999).
    • (1999) N. Engl. J. Med. , vol.341 , Issue.25 , pp. 1882-1890
    • Buxton, A.E.1    Lee, K.L.2    Fisher, J.D.3    Josephson, M.E.4    Prystowsky, E.N.5    Hafley, G.6
  • 68
    • 2442479695 scopus 로고    scopus 로고
    • Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
    • Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure Trial: both CRT-D and CRT-P showed significant overall mortality benefit. While CRT-D demonstrated a beneficial effect on cardiovascular mortality, CRT-P showed a trend toward this
    • Bristow MR, Saxon LA, Boehmer J et al.: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 350(21), 2140-2150 (2004). Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure Trial: both CRT-D and CRT-P showed significant overall mortality benefit. While CRT-D demonstrated a beneficial effect on cardiovascular mortality, CRT-P showed a trend toward this.
    • (2004) N. Engl. J. Med. , vol.350 , Issue.21 , pp. 2140-2150
    • Bristow, M.R.1    Saxon, L.A.2    Boehmer, J.3
  • 69
    • 16844364826 scopus 로고    scopus 로고
    • The effect of cardiac resynchronization on morbidity and mortality in heart failure
    • Cardiac resynchronization-Heart Failure trial: CRT-P resulted in a significant reduction in overall mortality when compared with optimal medical therapy. Comparison with CRT-D was not performed
    • Cleland JG, Daubert JC, Erdmann E et al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med. 352(15), 1539-1549 (2005). Cardiac resynchronization-Heart Failure trial: CRT-P resulted in a significant reduction in overall mortality when compared with optimal medical therapy. Comparison with CRT-D was not performed.
    • (2005) N. Engl. J. Med. , vol.352 , Issue.15 , pp. 1539-1549
    • Cleland, J.G.1    Daubert, J.C.2    Erdmann, E.3
  • 70
    • 9844224486 scopus 로고    scopus 로고
    • A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
    • The Antiarrhythmics Versus Implantable Defibrillators (AVID) investigators
    • A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics Versus Implantable Defibrillators (AVID) investigators. N. Engl. J. Med. 337(22), 1576-1583 (1997).
    • (1997) N. Engl. J. Med. , vol.337 , Issue.22 , pp. 1576-1583
  • 71
    • 0034696531 scopus 로고    scopus 로고
    • Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone
    • Connolly SJ, Gent M, Roberts RS et al.: Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101(11), 1297-1302 (2000).
    • (2000) Circulation , vol.101 , Issue.11 , pp. 1297-1302
    • Connolly, S.J.1    Gent, M.2    Roberts, R.S.3
  • 72
    • 0037696634 scopus 로고    scopus 로고
    • Defibrillator Versus β-Blockers for Unexplained Death in Thailand (DEBUT): A randomized clinical trial
    • Nademanee K, Veerakul G, Mower M et al.: Defibrillator Versus β-Blockers for Unexplained Death in Thailand (DEBUT): a randomized clinical trial. Circulation 107(17), 2221-2226 (2003).
    • (2003) Circulation , vol.107 , Issue.17 , pp. 2221-2226
    • Nademanee, K.1    Veerakul, G.2    Mower, M.3
  • 73
    • 3142656526 scopus 로고    scopus 로고
    • The Midlands trial of empirical Amiodarone Versus Electrophysiology- guided interventions and implantable cardioverter-defibrillators (MAVERIC): A multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death
    • Lau EW, Griffith MJ, Pathmanathan RK et al.: The Midlands trial of empirical Amiodarone Versus Electrophysiology-guided interventions and implantable cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death. Europace 6(4), 257-266 (2004).
    • (2004) Europace , vol.6 , Issue.4 , pp. 257-266
    • Lau, E.W.1    Griffith, M.J.2    Pathmanathan, R.K.3
  • 75
    • 77955258960 scopus 로고    scopus 로고
    • β-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: Implications for patient management
    • doi: 10.1111/j.1540-8167.2010.01737.x Epub ahdead of print. Study provides evidence for further risk stratification of high-risk patients with long QT syndrome and tailored use of medical therapy versus medical therapy and ICD
    • Goldenberg I, Bradley J, Moss A et al.: β-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management. J. Cardiovasc. Electrophysiol. doi: 10.1111/j.1540-8167.2010.01737.x (2010) (Epub ahdead of print). Study provides evidence for further risk stratification of high-risk patients with long QT syndrome and tailored use of medical therapy versus medical therapy and ICD.
    • (2010) J. Cardiovasc. Electrophysiol.
    • Goldenberg, I.1    Bradley, J.2    Moss, A.3
  • 76
    • 0028874658 scopus 로고
    • + channel blockade and to increases in heart rate. Implications for gene-specific therapy
    • + channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 92(12), 3381-3386 (1995).
    • (1995) Circulation , vol.92 , Issue.12 , pp. 3381-3386
    • Schwartz, P.J.1    Priori, S.G.2    Locati, E.H.3
  • 77
    • 18844390428 scopus 로고    scopus 로고
    • Specific therapy based on the geotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome
    • Shimizu W, Aiba T, Antzelevitch C: Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome. Curr. Pharm. Des. 11(12), 1561-1572 (2005).
    • (2005) Curr. Pharm. Des. , vol.11 , Issue.12 , pp. 1561-1572
    • Shimizu, W.1    Aiba, T.2    Antzelevitch, C.3
  • 78
    • 53049104215 scopus 로고    scopus 로고
    • Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome
    • Moss AJ, Zareba W, Schwarz KQ, Rosero S, McNitt S, Robinson JL: Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J. Cardiovasc. Electrophysiol. 19(12), 1289-1293 (2008).
    • (2008) J. Cardiovasc. Electrophysiol. , vol.19 , Issue.12 , pp. 1289-1293
    • Moss, A.J.1    Zareba, W.2    Schwarz, K.Q.3    Rosero, S.4    McNitt, S.5    Robinson, J.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.